Gyroscope Therapeutics

Now a part of Novartis, this organization develops gene therapies for the treatment of serious ocular diseases. The company focuses on advancing a pipeline of transformative treatments through technology platforms in neuroscience and regenerative medicine. Its operations support the research and development of high-value medicines for patients and healthcare professionals globally.